RAYMOND DEBBANE Insider Trading $LEXG LEXICON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAYMOND DEBBANE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAYMOND DEBBANE. RAYMOND DEBBANE is Director in WEIGHT WATCHERS INTERNATIONAL INC ($WTW) and Director in LEXICON PHARMACEUTICALS, INC. ($LEXG) and Director in Blue Buffalo Pet Products, Inc. ($BUFF).
RAYMOND DEBBANE in LEXICON PHARMACEUTICALS, INC.
Trading Symbol: LEXGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RAYMOND DEBBANE: Director
Holdings: 327,521 shares
Current Value: $0
Latest Transaction: May 03 2021
$LEXG Market Capitalization: $796343.50
$LEXG Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RAYMOND DEBBANE in LEXICON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BUFF, LEXG, WTW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 10,638 | 0 | 327,521 | 316.9 K to 327.5 K (+3.36 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 10,638 | 0 | 327,521 | 316.9 K to 327.5 K (+3.36 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 3,466 | 0 | 316,883 | 313.4 K to 316.9 K (+1.11 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.80 | 3,400 | 9,520 | 313,417 | 310 K to 313.4 K (+1.10 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.79 | 7,500 | 20,925 | 310,017 | 302.5 K to 310 K (+2.48 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.78 | 3,900 | 10,842 | 302,517 | 298.6 K to 302.5 K (+1.31 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.77 | 12,400 | 34,348 | 298,617 | 286.2 K to 298.6 K (+4.33 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.76 | 4,500 | 12,420 | 286,217 | 281.7 K to 286.2 K (+1.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.75 | 6,853 | 18,846 | 281,717 | 274.9 K to 281.7 K (+2.49 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.74 | 1,900 | 5,206 | 274,864 | 273 K to 274.9 K (+0.70 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.73 | 11,100 | 30,303 | 272,964 | 261.9 K to 273 K (+4.24 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.72 | 8,082 | 21,983 | 261,864 | 253.8 K to 261.9 K (+3.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.71 | 6,443 | 17,461 | 253,782 | 247.3 K to 253.8 K (+2.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.70 | 400 | 1,080 | 247,339 | 246.9 K to 247.3 K (+0.16 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.69 | 500 | 1,345 | 246,939 | 246.4 K to 246.9 K (+0.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.68 | 1,300 | 3,484 | 246,439 | 245.1 K to 246.4 K (+0.53 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.67 | 4,600 | 12,282 | 245,139 | 240.5 K to 245.1 K (+1.91 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.66 | 1,100 | 2,926 | 240,539 | 239.4 K to 240.5 K (+0.46 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.64 | 2,100 | 5,544 | 239,439 | 237.3 K to 239.4 K (+0.88 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.63 | 4,800 | 12,624 | 237,339 | 232.5 K to 237.3 K (+2.06 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.62 | 3,110 | 8,148 | 232,539 | 229.4 K to 232.5 K (+1.36 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.61 | 5,795 | 15,125 | 229,429 | 223.6 K to 229.4 K (+2.59 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.60 | 3,990 | 10,374 | 223,634 | 219.6 K to 223.6 K (+1.82 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.47 | 400 | 988 | 219,644 | 219.2 K to 219.6 K (+0.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.46 | 8,869 | 21,818 | 219,244 | 210.4 K to 219.2 K (+4.22 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.46 | 100 | 246 | 210,375 | 210.3 K to 210.4 K (+0.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.45 | 3,800 | 9,310 | 210,275 | 206.5 K to 210.3 K (+1.84 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.45 | 100 | 245 | 206,475 | 206.4 K to 206.5 K (+0.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.44 | 29,880 | 72,907 | 206,375 | 176.5 K to 206.4 K (+16.93 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.44 | 1,700 | 4,140 | 176,495 | 174.8 K to 176.5 K (+0.97 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.43 | 18,051 | 43,864 | 174,795 | 156.7 K to 174.8 K (+11.52 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.43 | 900 | 2,183 | 156,744 | 155.8 K to 156.7 K (+0.58 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.42 | 15,582 | 37,708 | 155,844 | 140.3 K to 155.8 K (+11.11 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.42 | 200 | 483 | 140,262 | 140.1 K to 140.3 K (+0.14 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.41 | 24,772 | 59,701 | 140,062 | 115.3 K to 140.1 K (+21.49 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 34,087 | 81,809 | 115,290 | 81.2 K to 115.3 K (+41.98 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 152 | 365 | 81,203 | 81.1 K to 81.2 K (+0.19 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 1,200 | 2,874 | 81,051 | 79.9 K to 81.1 K (+1.50 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.39 | 21,652 | 51,748 | 79,851 | 58.2 K to 79.9 K (+37.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.38 | 28,225 | 67,176 | 58,199 | 30 K to 58.2 K (+94.16 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.38 | 400 | 950 | 29,974 | 29.6 K to 30 K (+1.35 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.37 | 5,494 | 13,021 | 29,574 | 24.1 K to 29.6 K (+22.82 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.36 | 2,068 | 4,880 | 24,080 | 22 K to 24.1 K (+9.39 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.36 | 200 | 471 | 22,012 | 21.8 K to 22 K (+0.92 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.35 | 1,700 | 3,995 | 21,812 | 20.1 K to 21.8 K (+8.45 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.34 | 1,101 | 2,576 | 20,112 | 19 K to 20.1 K (+5.79 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.33 | 1,300 | 3,029 | 19,011 | 17.7 K to 19 K (+7.34 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.32 | 2,309 | 5,357 | 17,711 | 15.4 K to 17.7 K (+14.99 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.31 | 500 | 1,155 | 15,402 | 14.9 K to 15.4 K (+3.36 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.30 | 800 | 1,840 | 14,902 | 14.1 K to 14.9 K (+5.67 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.29 | 300 | 687 | 14,102 | 13.8 K to 14.1 K (+2.17 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.28 | 300 | 684 | 13,802 | 13.5 K to 13.8 K (+2.22 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.27 | 400 | 908 | 13,502 | 13.1 K to 13.5 K (+3.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.25 | 200 | 450 | 13,102 | 12.9 K to 13.1 K (+1.55 %) |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
May 02 2016 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
May 02 2016 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
Page: 1